NASDAQ: SGMT

Sagimet Biosciences Inc Stock Forecast, Predictions & Price Target

The consensus among 4 Wall Street analysts covering (NASDAQ: SGMT) stock is to Strong Buy SGMT stock.

Out of 4 analysts, 1 (25%) are recommending SGMT as a Strong Buy, 3 (75%) are recommending SGMT as a Buy, 0 (0%) are recommending SGMT as a Hold, 0 (0%) are recommending SGMT as a Sell, and 0 (0%) are recommending SGMT as a Strong Sell.

If you're new to stock investing, here's how to buy Sagimet Biosciences stock.

(NASDAQ: SGMT) Sagimet Biosciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Sagimet Biosciences's revenue in 2024 is $2,000,000.On average, 3 Wall Street analysts forecast SGMT's revenue for 2028 to be $1,678,670,456, with the lowest SGMT revenue forecast at $428,603,502, and the highest SGMT revenue forecast at $3,047,776,209. On average, 3 Wall Street analysts forecast SGMT's revenue for 2029 to be $5,963,365,097, with the lowest SGMT revenue forecast at $2,828,655,460, and the highest SGMT revenue forecast at $11,313,472,942.

In 2030, SGMT is forecast to generate $15,557,541,204 in revenue, with the lowest revenue forecast at $9,675,333,122 and the highest revenue forecast at $21,439,749,287.

According to 4 Wall Street analysts that have issued a 1 year SGMT price target, the average SGMT price target is $31.75, with the highest SGMT stock price forecast at $46.00 and the lowest SGMT stock price forecast at $23.00.

On average, Wall Street analysts predict that Sagimet Biosciences's share price could reach $31.75 by May 16, 2025. The average Sagimet Biosciences stock price prediction forecasts a potential upside of 587.23% from the current SGMT share price of $4.62.